Xref: utzoo sci.bio:2323 soc.motss:20294 Path: utzoo!utgpu!jarvis.csri.toronto.edu!mailrus!ames!pacbell!pbhyd!rjw From: rjw@PacBell.COM (Rod Williams) Newsgroups: sci.bio,soc.motss Subject: Re: Why AZT is so expensive Message-ID: <1428@pbhyd.PacBell.COM> Date: 19 Sep 89 18:21:56 GMT References: <26871@shemp.CS.UCLA.EDU> <1187@nih-csl.UUCP> <2434@aecom.yu.edu> <1704@hydra.riacs.edu> <2446@aecom.yu.edu> <1711@hydra.riacs.edu> <4612@ursa-major.SPDCC.COM> Reply-To: rjw@PacBell.COM (Rod Williams) Followup-To: sci.bio Organization: Pacific Bell Enclave at Bellcore Lines: 30 >You probably know now that today B-W lowered the price of AZT from >roughly $1.50/capsule to $1.20. In today's (9/19) New York Times, the article reporting this also includes : Robert Uhl, a pharmaceutical analyst with Salomon Brothers in New York said he believes the company [Burroughs-Wellcome] has already recovered its initial investment in the drug, which has been estimated at $80 million to $180 million. Estimates of the company's annual profit from the drug now range from $25 million to $100 million per year, depending on how they are calculated. Estimates of the cost of producing the $1.20 capsule, aside from research and development, range from 7 to 15 cents per capsule, by Dr. Mathilde Krim of the American Foundation for AIDS Research, to 33 to 53 cents, by industry analysts. The article also says that people with 'advanced cases of AIDS' need 12 capsules per day, while asymptomatic HIV+ people generally take 5 capsules per day. More than 20,000 people worldwide are currently taking AZT. That's expected to rise to 100,000 as a result of the recent studies showing its effectiveness in delaying the onset of the disease in asymptomatic HIV+ people, with perhaps 'several hundred thousand more' eligible to take it. -- Rod Williams * * * * * * * * * * * * * * * * * * * * * Bellcore * Don't hang about in the closet - * Piscataway, New Jersey * Wear yourself out! *